Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID
NCT07714889
Anxiety, Anxiety Disorders
View Trial DetailsNCT Number: NCT06652074
To assess the prevalence and severity of symptoms related to depression, anxiety, and stress, among population of resident doctors in Upper Egypt in Assiut University Hospitals and other hospitals in upper Egypt
Trial opening soon.
Get Notified20 year and older
All sexes
Observational
Many resident doctors during their training experience different levels of stress and this continuous pressure can cause feelings of discouragement and dissatisfaction, which might lead to the desire of leaving a training program.
This pressure could be accompanied by anxiety and depression and have negative effects on clinical performance and even increase the risk of burnout. Adjusting to these hectic job burdens affects individual emotional and intellectual contingency, and the capacity to create a healthy home-work balance. Burnout in residents can have serious effects not only on personal well-being, interpersonal relationships as well as on career but also may have negative effects on patient care .
The prevalence and impact of mental health issues among resident doctors have garnered increasing attention in recent years. Studies suggest that residency training can exacerbate existing vulnerabilities and contribute to the development of mental health disorders. The implications of these conditions are profound, affecting not only the personal well-being of the doctors but also their professional performance, patient care quality, and overall healthcare system efficiency.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
To assess the prevalence of symptoms related to depression, anxiety, and stress, among population of resident doctors in Upper Egypt in Assiut University Hospitals and other hospitals in upper Egypt by using the Depression, Anxiety and Stress Scale - 21 (DASS-21)
Time frame: 2 years
To assess the severity of symptoms related to depression, anxiety,and stress by using the Depression, Anxiety and Stress Scale - 21 (DASS-21)
Contact information is provided by the study sponsor or research team.
Ehab-Eldeen M Kamel, Prof
CONTACT
Hossam El-Deen A Khalifa, Prof
CONTACT
Assiut University
Other
Prevalence and Severity of Depression, Anxiety and Stress in a Sample of Resident Doctors in Upper Egypt.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07714889
Anxiety, Anxiety Disorders
View Trial DetailsNCT07503093
Anxiety, Anxiety Disorders
Belmont, Massachusetts, United States
View Trial DetailsNCT07639827
Anxiety, Anxiety Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT07627204
Anxiety, Anxiety Disorders
Lørenskog, Akershus, Norway
View Trial Details